Altogether, the overexpression of ERG in prostate cancer is a key modulator of tumor progression and aggressiveness, as it can regulate the transcription of the proteins that mediate inflammation, cell invasion, differentiation, and oncogenesis [43]. The gene discussed is ERG; the disease is Familial prostate cancer.